Trials / Enrolling By Invitation
Enrolling By InvitationNCT07032376
A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation
Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation- Phase 2
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 109 (estimated)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research is studying how the availability of a Food and Drug Administration (FDA)-cleared point-of-care, bedside device bedside device called Rectal Expulsion Device (RED) can be used to evaluate constipation in the participants' routine office visit with the participants' care provider. In this research, participants will be asked to complete a survey prior to the gastroenterology office consultation. Health-related information will be collected for this research study. There are no additional study visits for this research study.
Detailed description
This registration is (Implementation Phase) for the registered study "Guideline to Implementation: A Rapid Clinical Care Pathway to Care for Patients Affected by Chronic Constipation" (Observational Phase) NCT06352827.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Survey | All participants will complete a baseline survey and have medical information collected. |
| BEHAVIORAL | Rectal Expulsion Device use | During the participant's clinic visit for constipation, the Rectal Expulsion Device will be available for the gastroenterology care provider to use if the decision is made to use this during the clinic visit. In addition, the care provider will have access to the RED brochure and the Michigan Chart (MICHART) Our Practice Advisory (OPA) - a decision support tool in MiChart to support care navigation using RED. |
Timeline
- Start date
- 2025-08-20
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2025-06-24
- Last updated
- 2025-09-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07032376. Inclusion in this directory is not an endorsement.